TruScreen (ASX:TRU): Interview with CEO Juliet Hull
June 8, 2021
We spoke with TruScreen Group (ASX:TRU) CEO Juliet Hull from New Zealand about the opportunity of the TruScreen technology in emerging markets to provide a lower cost and more patient friendly alternative for cervical cancer diagnosis. In particular we talked about the Chinese market, which is expected to be a significant value driver.
Stocks Down Under … Must-have information for the serious investor!
Get Marc & Stuart’s Top Picks
Improve your investment skills with our Investor Webinars
Learn about ASX-listed stocks with our 4 editions per week across all sectors
Get access to everything with a 30-day FREE TRIAL.
No credit card required!